RPCEC00000395尚未招募1 期
Evaluation of the effect and safety of combined Moringa / Metformin treatment versus metformin in patients with type 2 diabetes mellitus. Exploratory study.
Research Center for Protein Plants and Bionatural Products0 个研究点目标入组 66 人开始时间: 2021年11月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Treatment
入排标准
- 年龄范围
- 19 years 至 75 years（—）
- 性别
- All
入选标准
- •1. Patients who meet the diagnostic criteria.
- •2. Adults 19-75 years
- •3. Initial HbA1c =7% = 9%
- •4. Patients who have given their informed consent to participate in the study.
排除标准
- •1. Patients who, before starting the study, present elevations of: glutamic oxaloacetic transaminase, glutamic pyruvic transaminase, total bilirubin, or alkaline phosphatase greater than or equal to 2.5 times the institutional upper normal limit.
- •2. Patients who, before starting the study, present a glomerular filtration rate of less than 60 ml / min according to the Cockcroft-Gault formula.
- •3. Patients treated with steroids by any route of administration 3 months before starting the study.
- •4. Patients with unstable ischemic heart disease or decompensated arterial hypertension.
- •5. Patients being treated with insulin or another hypoglycemic agent other than Metformin.
- •6. Patients with decompensated diabetic complications that require treatment.
- •7. Anticoagulated patients or those with blood dyscrasias and hemolytic anemia.
- •8. Pregnant and postpartum and breastfeeding patients.
研究者
相似试验
Unknown
4 期
Studying the Efficacy and Safety of Combined Moxifloxacin-Dexamethasone Eye Drops for the prevention of infection after Cataract SurgeryCTRI/2021/12/038392Aristopharma Ltd
尚未招募
不适用
Study on dose-effect relationship and safety of Modified Huangqi Chifeng Decoction with different doses of Astragalus in the treatment of IgA nephroproteinuriaITMCTR2000004074Xiyuan Hospital, China Academy of Chinese Medical Sciences
尚未招募
1 期
imotuzumab in the treatment of patients with acute respiratory difficulty syndrome (ARDS)Acute respiratory distress syndrome (ARDS)Respiratory Distress SyndromeLung DiseasesRespiratory Tract DiseasesRespiration DisordersRPCEC00000418Center of Molecular Immunology (CIM)74
招募中
1 期
This is a phase 2, randomized, double blind, multicenter study evaluating the efficacy and safety of the combination of methotrexate plus UVB TL01 in vitiligo.Vitiligo with new lesions or extension of old lesions during the last 6 monthsCTIS2024-512766-34-00Centre Hospitalier Universitaire De Bordeaux48
招募中
4 期
Type II Diabetic STUDYCTRI/2016/01/006486SV Limited270